Alio develops a remote patient monitoring technology to facilitate better care and reduce avoidable hospitalizations.
Alio develops a remote patient monitoring technology to facilitate better care and reduce avoidable hospitalizations. This technology measures metrics like skin temperature, oxygen saturation, pulse rate variability, blood pressure, potassium, and hemoglobin/hematocrit to help physicians with actionable real-time data to make the most informed medical decisions possible.It was founded in 2012 and is headquartered in Broomfield, Colorado.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 8, 2022 | Series C | $18M | 3 | Widjaja Family | — | Detail |
Jun 30, 2021 | Series B | $20M | 2 | Thomas Krebs | — | Detail |
Feb 1, 2020 | Convertable Note | — | 1 | — | — | Detail |
Dec 20, 2017 | Series A | $7.50M | — | — | — | Detail |
Sep 9, 2016 | Series Unknown | — | 1 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Widjaja Family | Yes | Series C |
Chasefield Capital | — | Series C |
Thomas Krebs | — | Series C |
Zekavat Investment Group | — | Series B |
AIoT Health | — | Convertable Note |
Dreamit Ventures | — | Series Unknown |
Maryland Venture Fund | — | Seed |